Indonesia PET Scan Market Analysis

Indonesia PET Scan Market Executive Summary

The Indonesia PET Scan market is at around $11.6 Mn in 2023 and is projected to reach $16.8 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period.

Positron Emission Tomography (PET) Scan is an advanced diagnostic and imaging technique which effectively identifies a variety of health issues such as cancer, heart disease, and brain disorders. It aids in the initial diagnosis and also in monitoring of the conditions for planning the treatment course. There are various types of PET scan including whole body PET scan. In whole body PET scan, the images of the entire body from head to toe are detected. A radiotracer is injected into the body which gets absorbed by all the tissues in the body. The scanner then detects the emitted radiation and creates detailed images of the organs and tissues. A whole-body PET scan is typically used to detect cancer, determine the stage of cancer, and monitor the treatment effectiveness. This type of scan is particularly useful for metastasis detection as it can identify even small tumors which might not be identified through other imaging tests. Another type of PET scan, called DOTATATA PET scan is used which is highly sensitive and specific for diagnosing neuroendocrine tumors (NETs). It utilizes a radiotracer called Gallium-68 DOTATATE, which combines somatostatin analog (DOTATATE) with a radioactive isotope (Gallium-68). The radiotracer targets somatostatin receptors which are often over expressed on the neuroendocrine tumors, allowing for the detection of both primary and metastatic NETs. A PSMA PET Scan is another type of PET scan used to detect, stage, and monitor prostate cancer. PSMA is the short for Prostate-Specific Membrane Antigen, which is overexpressed on the prostate cancer cells.

Indonesia faces a significant challenge in managing the burden of chronic diseases on its healthcare system, which has directly led to increased rates of morbidity and mortality in the country. The Indonesia PET Scan Market is thus driven by significant factors such as the expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. However, the high cost, limited availability of radiotracers, and competition from other imaging techniques restrict the growth and potential of the market.

The leading players of the Indonesia PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.

Market Dynamics

Market Growth Drivers

Expanding Applications in Medical Field: Traditionally focused on cancer diagnosis and staging, PET scans are now being utilized for a broader range of medical conditions. This includes cardiology, where they assess blood flow, identify heart damage, and evaluate treatments for heart failure, as well as neurology for diagnosing and monitoring neurodegenerative diseases like Alzheimer’s and Parkinson’s, migraines, and seizures. Investigations are also underway for using PET scans in diagnosing autoimmune diseases, assessing organ transplant rejection, and evaluating treatment responses. This expanded usage is increasing market demand, by attracting new customers to PET scan suppliers and manufacturers.

Advantages Over Other Imaging Techniques: PET scans offer significant advantages by enabling functional imaging that uncovers metabolic activity within tissues. This is particularly useful in oncology for differentiating between malignant and benign tumours based on their metabolic profiles. PET scans can detect cellular changes earlier than CT or MRI, which typically identify structural changes, thus allowing for prompt diagnosis and intervention. Moreover, PET scans provide whole-body imaging, crucial for staging cancers and identifying metastases throughout the body, a capability that CT and MRI often lack as they are focused on specific anatomical regions. These benefits are exceptional for treatments and this increases the market growth.

Technological Advancements: PET scan technology has seen remarkable advancements, enhancing diagnostic precision and patient outcomes. The introduction of innovative radiotracers with improved specificity for various biochemical targets such as protein synthesis and glucose metabolism has enabled more accurate disease imaging. Advances in detector technology, such as time-of-flight (TOF) PET and solid-state detectors, have improved sensitivity and spatial resolution, allowing for detailed visualization of small lesions and structures. PET-CT hybrid imaging combines anatomical and metabolic evaluations in one session, especially beneficial for brain and soft tissue assessments, driving growth in the PET scan market.

Market Restraints

High Cost: The substantial expense associated with PET scans includes not only the cost of the scanning process but also the radiopharmaceuticals used and the expensive scanners. This significant financial requirement can be a deterrent for both patients and healthcare providers, especially in areas with tight healthcare budgets. Moreover, the operational and maintenance expenses add to the overall cost. Market growth could be limited if these costs remain high or if reimbursement regulations become more stringent.

Limited Availability of Radiotracers: Many radiotracers used in PET scans have short half-lives, requiring rapid production and use. This necessitates closeness to production facilities with cyclotrons and radiochemistry labs, which may not be feasible in rural or undeveloped regions. The production and widespread distribution of radiotracers require sophisticated technology and adherence to stringent regulations. The supply limitations, due to technical, regulatory, and logistical challenges, restrict the expansion of the PET scan market.

Competition from other Imaging Techniques: Well-established imaging techniques like SPECT, CT, and MRI provide strong competition for PET scans. These methods are often more cost-effective, which makes them more attractive to patients. Their widespread availability and accessibility contribute to a higher preference for these traditional methods, thereby impacting the growth of the PET scan market. The established status of these older techniques presents a significant challenge for PET Scans Market.

Regulatory Landscape and Reimbursement Scenario

In Indonesia, the regulatory agency is called the National Agency of Drug and Food Control (NADFC), also known by its Indonesian name, Badan Pengawas Obat dan Makanan (BPOM) which operates under the Ministry of Health. It plays a critical role in ensuring the safety, efficacy, and quality of pharmaceuticals available in the nation.

The NADFC conducts detailed review and analysis of the applications from pharmaceutical companies to register and market the new drugs. It includes a thorough evaluation of the safety, efficacy, and quality of pharmaceutical products. After the NADFC is ensured of these characteristics, does it allow the drugs to be marketed. The NADFC is also responsible for post-marketing surveillance of the drugs in case of any reporting of adverse drug reactions.

Indonesia’s healthcare reimbursement system is a complex mix of public and private insurance schemes. The mandated national health insurance scheme in Indonesia is called Jaminan Kesehatan Nasional (JKN), or National Health Insurance. It attempts to give access to basic healthcare and covers a sizable section of the populace. The JKN reimburses healthcare costs for outpatient and inpatient services at the designated healthcare facilities. For the private sector, compared to the JKN, private health insurance plans may provide greater coverage and better reimbursement rates.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia PET Scan Market:

• GE Healthcare
• Siemens Healthineers
• Toshiba
• Schiller
• Hitachi
• Canon Medical Systems
• Philips
• Fujifilm
• Neusoft Medical
• United Imaging Healthcare